Highlights 3Q13. Affinity Health Net adds. Affinity Health Portfolio. % change 3Q13/4Q12

Size: px
Start display at page:

Download "Highlights 3Q13. Affinity Health Net adds. Affinity Health Portfolio. % change 3Q13/4Q12"

Transcription

1

2 Disclaimer The material that follows is a confidential presentation of general background information about Qualicorp S.A. and its subsidiaries (collectively, Qualicorp or the Company ) as of the date of the presentation. It is information in summary form and does not purport to be complete. No representation or warranty, express or implied, is made concerning, and no reliance should be placed on, the accuracy, fairness, or completeness of this information. This confidential presentation may contain certain forward-looking statements and information relating to Qualicorp that reflect the current views and/or expectations of Qualicorp and its management with respect to its performance, business and future events. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like anticipate, believe, estimate, expect, forecast, plan, predict, project, target or any other words or phrases of similar meaning. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this presentation, including: market acceptance of Qualicorp s products or services; volatility in the healthcare industry, the Brazilian economy and the financial markets; changes in legislation, accounting standards, taxation and government policies affecting the healthcare sector; ability to stay abreast of changes in technology; ability to continuously introduce competitive new products and services, while staying competitive in existing ones. In no event, neither Qualicorp nor any of its affiliates, directors, officers, agents or employees, nor the selling shareholder, placement agents or underwriters, shall be liable before any third party (including investors) for any investment or business decision made or action taken in reliance on the information and statements contained in this presentation or for any consequential, special or similar damages. All forward-looking statements in this presentation are based on information and data available as of the date they were made, and Qualicorp undertakes no obligation to update them in light of new information or future developments. This presentation and its contents are proprietary information and may not be reproduced or otherwise disseminated in whole or in part without Qualicorp s prior written consent. Securities may not be offered or sold in the United States unless they are registered or exempt from registration under the United States Securities Act of 1933, as amended. Any offering of securities to be made in the United States will be made solely by means of a confidential offering memorandum that may be obtained from the placement agents or the underwriters. Such confidential offering memorandum will contain detailed information about Qualicorp and its business and financial results, as well as its financial statements. This presentation does not constitute an offer, or invitation, or solicitation of an offer, to subscribe for or purchase any securities. Neither this presentation nor anything contained herein shall form the basis of any contract or commitment whatsoever. 2

3 Thousand Highlights 3Q13 Qualicorp reached strong gross sales in 3Q13 (average 37k/month) as a consequence of: (i) maturation of new regions; (ii) offering of new products / operators; and (ii) a more efficient sales force; Churn remained higher than historical, increasing less than expected if we consider the typical seasonality of third quarters. Even with a high churn level we could present a sequential improvement. Affinity Health Portfolio Affinity Health Net adds Portfolio 3Q13 3Q12 % change 3Q13/4Q12 2Q13 % change 3Q13/2Q13 Affinity Health Lives Total Portfolio (BOP) 1,322,246 1,039, % 1,275, % (+) Gross Adds 111, ,564¹ -58.8% 123, % (-) Churn (85,994) (57,609) 49.3% (76,755) 12.0% New Lives Added (net) 25, , % 46, % Total Portfolio (EOP) 1,347,712 1,252, % 1,322, % ¹ Includes Padrão and Aliança. Source: Company Data Q12¹ 4Q12 1Q13 2Q13 3Q13 Net Sales - Affinity Health ¹ During 3Q12 we incorporated approximately 84k lives from Grupo Padrão and 100k lives from Grupo Aliança. Source: Company Data. 3

4 R$ Million Highlights 3Q13 Our EBITDA margin reached 38.8%, which represents an improvement of 248bps when compared to 3Q12, even with a higher bad debt (+100pp) which shows our operational leverage in other expense lines of the income statement. In a sequential comparison, the margin expansion was even higher (361bps) Adjusted due EBITDA to the and dilution EBITDA of Margin expenses and bad debt reduction. Provision for Doubtful Accounts (PDA) % 37% 36.9% % 32.8% % Q12 3Q13 40% 39% 38% 37% 36% 35% 34% 33% 32% 31% 30% 29% 10,0% 9,0% 8,0% 7,0% 6,0% 5,0% 4,0% 3,0% 2,0% 1,0% 0,0% 6.0% 5.4% 5.8% 4.9% 7.4% 6.1% 9.3% 8.5% 8.4% 7.8% 8.1% 7.6% 7.1% Adjusted EBITDA EBITDA Margin Reported Pro forma Source: Company Data. ¹The Adjusted EBITDA is not audited and represents management view of the company results. It excludes stock option expenses, non-recurring expenses and adds the interest on late penalties. 4

5 Main messages We still see a number of opportunities for continued growth on gross adds Strategies to control churn post price readjustment partially offset its expected increase. Our strategies to keep PDA under control such as usage of collection agencies and SERASA are bearing fruits and should keep on. There are still more efficiency gains to absorb coming from: (i) new IT platform; (ii) initiatives to improve internal processes. We are confident that Qualicorp will emerge from this economic turmoil in a much better shape with improved internal controls, more robust distribution channel and cost control initiatives! 5

6 Industry Overview Relationship with Clients + Relationship with Providers (MLR Management) Client Health Plan +$ Operators -$ - Medical Providers Hyperinflation Private Healthcare Plan Law Creation of ANS ANS Regulations on Affinity Plans Present Until Junior - Individual Salesman First Affinity Contract Foundation of Qualicorp General Atlantic Carlyle IPO 6

7 Million Source: Caderno de Informação da Saúde Suplementar - ANS (09/2013). Industry Overview The Brazilian Private Healthcare Sector has approximately 49 million members, which represents 24.5% of the total population. The majority of the covered members are concentrated in Group plans : (i) 64.5% in corporate plans; and (ii) 13.4% in affinity group plans, which is the largest business for Qualicorp. Private Healthcare Sector Membership Growth Private Healthcare Sector Members Breakdown 1.9% % 19.3% 20.1% 21.0% 21.9% ,8% 22.2% 23.5% 24.1% % % Corporate Affinity 13.4% 64.5% Individual Uninformed Lives Covered % Covered Population Source: Caderno de Informação da Saúde Suplementar - ANS (09/2013) / IBGE. Group Individual Over the last two years group plans membership grew by 6.6% versus only 3% in the individual segment, as shown in Exhibit (2), which indicates a potential shift in preference given more competitive prices. 7

8 Industry Overview Number of Healthcare Operators in Brazil 99 Benefit Administrators (6.6%) ,723 2,407 2,639 2,709 2,178 2,067 2,273 2,091 1,930 1,762 1,618 1,538 1,695 1,601 1,497 Benefit Administrator Self Management Medical Cooperative Dental Cooperative Philanthropy Group Medicine Number of Operators Group Dental Health Insurance Company Source: Caderno de Informação da Saúde Suplementar - ANS (09/2013). According to ANS, Brazil has 1,497 active Healthcare operators. Out of those, 99 are benefit administrators like Qualicorp. Given the high level of fragmentation in the sector, we consider ourselves as leaders in this segment, with 1.8 million members in the affinity segment and 2.7 million in the corporate segment. 8

9 R$ Billion Industry Overview Private Healthcare Sector Revenues (R$) Operators Revenue X MLR % 81% 81% % % 80% % % % 84% Revenues MLR% Source: Caderno de Informação da Saúde Suplementar - ANS (09/2013). The Exhibit shows the evolution of the Healthcare sector revenues and MLR, indicating a strong expansion since 2003 but still high level of costs. We highlight that Qualicorp is not exposed to underwriting risks, which places the company in an unique position among the healthcare sector. At the same time, to guarantee the sustainability of our business we engage strong efforts to keep the MLR of our portfolio under control, enabling competitive prices and strong growth. 9

10 Leading, Full-Service Benefits Administrator in Brazil Affinity (Professional Associations) Partners with leading Brazilian professional associations and health plan operators to offer health plans to association members at reduced prices Offers value-added services to over 400 professional associations Direct relationship with beneficiaries Corporate and Other (Companies / HR) Benefits consultant and health plan broker Third-party administrator (TPA) Connectivity (Medlink) Mass insurance product sales (PraxiSolutions) 10 Qualicorp has a unique business model which provides access to high quality healthcare services to millions of Brazilians

11 Qualicorp Overview Relationship with Clients Relationship with Providers (MLR Management) Affinity/ Corporate Clients 91% Health Plan Operators Benefit Administration Health Management / Administration Individual Customers Collection and Services (Ownership) - Billing - Collection - Call center Medical Management Infrastructure Proprietary IT Knowledge/Intelligence Client Pool/Customer Base 3% TPA (Third-Party Administration) HCIT (Healthcare Information Technology) PBM (Pharmacy Benefit Management) PPO (Preferred Provider Organization) Services already offered by Qualicorp (under expansion) Being evaluated according to opportunity Medical Providers 6% Brokerage (Sales) - Scale - Sales Force Mass Insurance Products 11

12 Thousand Thousand Qualicorp - Segments Affinity Members Corporate and Others Members , , , , , , , , , ,262 1,253 1, Q12 3Q Q12 3Q13 Health New Products Corporate TPA SME Health Management Exhibits show the evolution of Qualicorp membership base growth divided by segment. We currently have over 4.5 million lives among affinity and corporate clients, and our most recent results (3Q13) show growth of 5.8% y/y in the affinity membership base and 7.1% in the corporate segment.

13 Thousand Qualicorp - Segments Professional Associations Affinity Health Net adds M13 Number of Professional Associations Q12¹ 4Q12 1Q13 2Q13 3Q13 Net Sales - Affinity Health Source: Company Data. We increased the number of partnered associations to 473 in 9M13, keeping the strong pace of growth. ¹ During 3Q12 we incorporated approximately 84k lives from Grupo Padrão and 100k lives from Grupo Aliança. Source: Company Data.

14 Qualicorp Adds Value to All Constituents in the Affinity Segment Individual Beneficiaries Improves access to private healthcare Discounts up to 50% compared to individual plans Additional value-added services Health Plan Operators Most effective way to address individuals Improves access to individual policyholders with attractive demographics and income profile Lower MLRs and zero delinquency Professional Associations Improves negotiating power Revenue-sharing agreements with Qualicorp provide source of income help attract new members Augments association database through tracking and data Management Brazilian Government 14 Improves accessibility of private healthcare system Alleviates burden on public healthcare system

15 Uniquely Positioned to Aggregate Interests and Demands in the Affinity Market Brokerage 1,000,00* Accountants Medical Lawyers Dentists Engineers Public Servants Others 200,000* 50,000* 250,000* 100,000* 100,000* 150,000* 150,000* Professional Associations * The numbers used in this example are for illustrative purposes only. 15

16 Qualicorp: Unique Business Model Brokerage (Sales) Benefits Administration We Own the Client ( Umbrella Contracts ) Marketing of products Direct marketing Database marketing Customer register Implement customer register changes Manage costs and utilization rates Provide distribution channels Send ID and manuals for the clients Manage conflicts between operator and beneficiaries Call center Sales Identify the best option for the customer Services Prepare invoice Charge the client Pass through the payment Contact companies and associations Enable healthcare services Clarify doubts regarding plans Monitor pregnancy and chronic diseases Originate beneficiaries Prepare proposal for clients Reimburse clients Manage hospitalization passwords Negotiate premium adjusments Discuss commercial terms with beneficiaries Healthcare and Preventive Medicine promotion Report changes in the terms negotiated Identify opportunities with operators and health insurance companies 16 BENEFICIARIES COMPANIES PROFESSIONAL ASSOCIATION

17 Traditional Business Model After Sales Administrative Services Commercial / Sales MLR - Health Management 17

18 Qualicorp s Business Model Qualicorp is uniquely positioned as a complete service provider along the entire healthcare value chain Health benefit administrator Monitor pregnancy and chronic diseases Processing of transactions Call center Enable health care services TPA Mass insurance products HCIT Brokerage PBM Benefits design consulting Management of risks PPO 18

19 Key Investment Highlights Fast Growing, Underpenetrated and Large Addressable Market Unique Business Model which Creates Value for All Constituents and Assumes No Underwriting nor Reimbursement Risk Leading Position with Significant Scale and Long-Standing Customer Relationships Multiple Opportunities for Continued Growth Strong Operational and Financial Performance Management Team Led by Respected Industry Pioneers Ongoing Organic Growth and Attractive Acquisition Opportunities 19

20 Expansion Plan Growth Strategy Multiple Avenues to Continue to Drive Long Term Sustainable Growth Geographic Expansion Cross-sell new products Opportunities from Market Evolution Acquisitions/Partnerships How We Have Delivered Added partnerships with operators nationwide, including unique opportunities with the three largest Brazilian healthcare plan operators Bradesco Saúde, Intermédica and Amil. Entered the emerging middle class market. Continued to leverage long-standing relationships with partners such as SulAmérica. Expanded geographically to new markets in Brazil. Organic Currently, Qualicorp is pursuing all of these growth avenues Strong organic growth in number of beneficiaries Track record of implementing multipronged growth strategies and tremendous room for future expansion 20

21 Significant Growth Opportunities Unparalleled Partnerships with the Largest Brazilian Health Plan Operators Growth Strategy Going Forward (Affinity Segment) Top Health Plan Operators in Brazil Add New Professional Associations Expand Membership of Existing Associations Deepen Penetration Within Existing Associations 21

22 Expand Geographically to New Markets in Brazil Belém Fortaleza Target high growth markets outside São Paulo and Rio de Janeiro Identify and prioritize attractive new regions with the support of specialized consulting companies Manaus Salvador Recife Utilize Bradesco Saúde, Amil and Intermédica s strong capabilities and brand names to support geographic expansion Brasília (DF) São Paulo Belo Horizonte Vitória Continue to leverage relationship with SulAmérica Curitiba Rio de Janeiro Porto Alegre 22

23 Expansion of Higher Income Class Dramatic Shift in Income Classes (1) Notes: (1) Classes A/B: monthly income above R$4,855 Class C: monthly income between R$1,126 and R$4,854 Class D: monthly income between R$706 and R$1,125 Class E: monthly income below R$705 Source: World Health Organization Statistics 2010 Data as of 2007, World Bank, ANS and Analise Institute. 23

24 Cross-Sell New Products and Services to Existing Customers Health Insurance Dental Life Insurance Personal Accident Insurance ExtrAssist Continue to leverage brand, exclusive association and provider relationships and existing customer base Capitalize on substantial cross-selling potential through PraxiSolutions acquisition to drive growth Identify additional products / geographies for cross-selling with support of specialized consulting firms Invest in marketing and advertising to increase awareness of Qualicorp s product offerings Cross-Selling Initiatives Deepen Relationship with Professional Associations and Improve Customer Stickiness 24

25 Leverage Existing Platform to Expand as Healthcare Market Evolves Third-Party Administrator (TPA) Leading TPA in Brazil Healthcare Information Technology (HCIT) Significant collection of medical data Acquisition of one of the largest connectivity companies in Brazil (Medlink) Mass Insurance Products Consists of a broad range of insurance products including life, accident, etc PBM and PPO Products Evaluated according to opportunity Services already provided by Qualicorp Services being evaluated by Qualicorp 25

26 Successful Execution of Acquisitions Grow Through Selective Acquisitions APRIL 2011 APRIL 2011 JULY 2011 OCTOBER 2011 Provides connectivity Provides approximately Adds mass insurance Provides individual and services to complement 60,000 additional lives to products to existing platform corporate collective Qualicorp s businesses the affinity portfolio and allows for cross-selling healthcare insurance already implemented in through distribution through a brokerage service the TPA segment channels across Brazil (2,000 distribution points) 26

27 Successful Execution of Acquisitions DECEMBER 2011 MARCH 2012 JULY 2012 AUGUST 2012 Expands geographic Adds new opportunities in Reinforces strategy to increase Reinforces position in the public presence and adds new the Corporate segment and penetration in Affinity Group Health segment, increase penetration in associations and providers expands Qualicorp s plans by adding 84,000 lives to Affinity Health plans by adding 140,000 geographic footprint portfolio, mainly in Rio de Janeiro and lives to Affinity/Corporate São Paulo and also in Paraná, Ceará portfolio, mainly in the Federal and the Federal District of Brazil District of Brazil Selected and disciplined acquisitions of affinity brokerage portfolios support growth Operational leverage: incremental contribution margin of more than 60% for every new affinity member Add new capabilities: (i) Continue to broaden product offering; (ii) Leverage track record of increasing cross-selling through PraxiSolutions acquisition 27

28 Revenue Streams Payer Individual Beneficiary Revenue to Qualicorp Membership Fee Benefits Admin Fee Recurrence Initial Monthly Health Plan Operator New Sales Fee Brokerage Royalty Initial Monthly Monthly Around 90% of all revenues are recurring 28

29 R$ Million R$ Million Financial Data Net Revenues Adjusted EBITDA and EBITDA Margin % % % % % 36.3% % Q12 3Q Q12 3Q13 Adjusted EBITDA EBITDA Margin Source: Company Data. Source: Company Data. ¹The Adjusted EBITDA is not audited and represents management view of the company results. It excludes stock option expenses, non-recurring expenses and adds the interest on late penalties. 29

30 R$ Million Financial Data Adjusted Earnings (R$) Our Adjusted Earnings consider adjustments from extraordinary expenses. During 3Q13 the adjustments refer only to non-cash Stock Option Plan expenses and to monetary adjustment in the call option to acquire Aliança (non-cash effect). During 3Q12 the adjustments refer to acquisition expenses, impairment, non-cash Stock Option Plan expenses and to monetary adjustment in the call option to acquire Aliança (non-cash effect). Adjusted for these factors, our earnings reached R$58.6 million in 3Q13, with an increase of 99.3% y/y % Q12 3Q13 Source: Company Data. 30

31 Financial Data Affinity Health Portfolio Portfolio 3Q13 3Q12 % change 3Q13/4Q12 2Q13 % change 3Q13/2Q13 Affinity Health Lives Total Portfolio (BOP) 1,322,246 1,039, % 1,275, % (+) Gross Adds 111, ,564¹ -58.8% 123, % (-) Churn (85,994) (57,609) 49.3% (76,755) 12.0% New Lives Added (net) 25, , % 46, % Total Portfolio (EOP) 1,347,712 1,252, % 1,322, % ¹ Includes Padrão and Aliança. Source: Company Data. The Exhibit shows an increase of 7.6% y/y (+1.9% q/q) in the gross additions, confirming the positive results of our sales strategy and geographic expansion. We still have opportunities to improve the churn level, which remains our main challenge for Among several actions, we are reinforcing the client retention area through the: (i) Insourcing of retention operations and change in management (specialization); (ii) creation of the Client Retention Committee; (iii) development of new services offered, etc. 31

32 Financial Data %PDA/Net Revenue 10,0% 9,0% 8,0% 7.4% 9.3% 8.4% 8.1% 7,0% 6,0% 6.0% 5.4% 8.5% 7.8% 7.6% 7.1% 5,0% 4,0% 5.8% 4.9% 6.1% 3,0% 2,0% 1,0% 0,0% Reported Pro forma Source: Company Data. The relevant variance of the churn level, which increased mostly due to the bad conditions of macroeconomic scenario and the acquired portfolios, has led to higher provisions for doubtful accounts. The company is putting in place several initiatives to contain PDA, including (i) stimulate direct debt; (ii) test sending the bad payers to the black list; (iii) hiring of specialized collection and consultancy agencies, etc. 32

33 Share Performance Ownership Breakdown 0.5% 6% 4% 1% Management Free Float L2 Participações FIP (Júnior) 27.3% 72.2% 12% 50% 27% Brazil USA Europe Asia Americas¹ Oceania Source: Company Data (09/30/2013). Our shareholder structure is organized as shown above. Júnior holds 27.3% of our shares, Management 0.5% and the remaining 72.2% is free float. Of the total free float, 73% are under foreigners funds and only 27% under locals. 33

34 Share Performance QUAL3 X IBOV QUAL3 (11/22/13) % IBOV (11/22/13) % IBOV Index QUAL3 BZ Equity Source: Company Data (10/22/2013). Since the IPO, Qualicorp shares presented a strong outperformance compared to BM&FBOVESPA index. While IBOV index presents a reduction of 15.3% since our IPO, our share price increased 65.4% in the same period. 34

35 Million Share Performance Historical Average Daily Trading Volume (R$) IPO Follow On Carlyle Sale Block Source: Company Data (10/22/2013). ¹On November 29th and 30th and December 4th of 2012, the volume was R$988.1, R$483.6 and R$366.4 million respectively mainly due to Carlyle s disposal of Qualicorp s shares. 35

36 36

Non-Deal Roadshow Presentation

Non-Deal Roadshow Presentation Non-Deal Roadshow Presentation 2 1 Disclaimer The material that follows is a confidential presentation of general background information about Qualicorp S.A. and its subsidiaries (collectively, Qualicorp

More information

30. 0% 25. 0% 20. 0% 15. 0% 10. 0%

30. 0% 25. 0% 20. 0% 15. 0% 10. 0% Disclaimer The material that follows is a confidential presentation of general background information about Qualicorp S.A. and its subsidiaries (collectively, Qualicorp or the Company ) as of the date

More information

Consolidated Income Statement - (R$ MM) 2Q16 2Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Consolidated Income Statement - (R$ MM) 2Q16 2Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q Qualicorp S.A. BOVESPA:QUAL3 Shares Outstanding (06/30/2016) 274.325.288 shares Free Float (06/30/2016) 215.096.548 shares (78.4%) Cash and Cash Equivalents (06/30/2016) R$333.2 million São Paulo, August

More information

QUALICORP REPORTS 2Q11 GROWTH IN THE NUMBER OF BENEFICIARIES (18.5%), NET REVENUEs (43.9%) AND ADJUSTED EBITDA (36.6%) AS COMPARED TO 2Q10 1

QUALICORP REPORTS 2Q11 GROWTH IN THE NUMBER OF BENEFICIARIES (18.5%), NET REVENUEs (43.9%) AND ADJUSTED EBITDA (36.6%) AS COMPARED TO 2Q10 1 QUALICORP REPORTS 2Q11 GROWTH IN THE NUMBER OF BENEFICIARIES (18.5%), NET REVENUEs (43.9%) AND ADJUSTED EBITDA (36.6%) AS COMPARED TO 2Q10 1 Sao Paulo, August 12th, 2011. Qualicorp SA (Bovespa: QUAL3),

More information

Consolidated Income Statement - (R$ MM) 1Q16 1Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Consolidated Income Statement - (R$ MM) 1Q16 1Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q Qualicorp S.A. BOVESPA:QUAL3 Last Price May 11 th, 2016 R$ 15.00/share São Paulo, May 11, 2016. QUALICORP S.A (BM&FBOVESPA: QUAL3), one of the leading full-service healthcare benefits administrator and

More information

Agenda 8:00 Breakfast / Registration 10:00 Q&A 10:40 Coffee Break 11:50 Q&A 12:30 Closing

Agenda 8:00 Breakfast / Registration 10:00 Q&A 10:40 Coffee Break 11:50 Q&A 12:30 Closing Agenda 8:00 Breakfast / Registration 8:30 CEO Presentation (José Seripieri Filho) 9:00 COO Presentation (Eduardo Noronha) 9:20 Presentation Commercial Affinity (Rafael Cavalcanti, Alberto Bulus and Leonardo

More information

Consolidated Income Statement - (R$ MM) Balance Sheet Equity 2, , % Net Debt¹

Consolidated Income Statement - (R$ MM) Balance Sheet Equity 2, , % Net Debt¹ Qualicorp S.A. BOVESPA:QUAL3 Shares Outstanding (12/31/2016) 278.794.088 shares Free Float (12/31/2016) 222.827.401 shares (79.9%) Cash and Cash Equivalents (12/31/2016) R$450,9 million Investor Relations

More information

Consolidated Income Statement - Balance Sheet 1Q Equity 2, , % Net Debt¹ % Other 1Q

Consolidated Income Statement - Balance Sheet 1Q Equity 2, , % Net Debt¹ % Other 1Q Qualicorp S.A. BOVESPA:QUAL3 Shares Outstanding (04/30/2017) 282,373,588 shares Free Float (04/30/2017) 236,056,267 shares (83.6%) Cash and Cash Equivalents (03/31/2017) R$688.1 million Investor Relations

More information

Consolidated Income Statement - (R$ MM) Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Consolidated Income Statement - (R$ MM) Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q Qualicorp S.A. BOVESPA: QUAL3 Shares Outstanding (3/30/2018) 283,176,825 shares São Paulo, May 10th 2018. QUALICORP S.A (B3: QUAL3), one of the leading full-service healthcare benefits trader, administrator

More information

Qualicorp Consultoria e Corretora de Seguros S.A.

Qualicorp Consultoria e Corretora de Seguros S.A. Qualicorp Consultoria e Corretora de B3: QUAL3 Shares Outstanding (9/28/2018) 283,176,826 shares Free Float (9/28/2018) 237,835,371 shares ( 84.0%) Cash and Cash Equivalents (9/28/2018) R$596.6 million

More information

Qualicorp Consultoria e Corretora de Seguros S.A.

Qualicorp Consultoria e Corretora de Seguros S.A. Qualicorp Consultoria e Corretora de BOVESPA: QUAL3 Shares Outstanding (6/30/2018) 283,176,826 shares Free Float (6/30/2018) 282,276,689 shares ( 99.7%) Cash and Cash Equivalents (6/30/2018) R$400.0 million

More information

From HMO to IPO the Brazilian Experience. Luiz Kaufmann. IFC INTERNATIONAL HEALTH CONFERENCE 2007 April 2007

From HMO to IPO the Brazilian Experience. Luiz Kaufmann. IFC INTERNATIONAL HEALTH CONFERENCE 2007 April 2007 From HMO to IPO the Brazilian Experience Luiz Kaufmann IFC INTERNATIONAL HEALTH CONFERENCE 2007 April 2007 IFC INTERNATIONAL HEALTH CONFERENCE 2007 April 2007 From HMO to IPO The Brazilian Experience Luiz

More information

Institutional Presentation

Institutional Presentation Institutional Presentation SulAmérica and Industry SULAMÉRICA BUSINESS MODEL Largest independent Brazilian insurer Multiline model One-stop shop and strong product cross selling Disciplined underwriting,

More information

Income Statement (Ex -CRC/Gam a) - Balance Sheet Equity¹ 1.993, ,8-15,4% Net Debt² 497,3 227,3 118,8% Other

Income Statement (Ex -CRC/Gam a) - Balance Sheet Equity¹ 1.993, ,8-15,4% Net Debt² 497,3 227,3 118,8% Other Qualicorp S.A. BOVESPA:QUAL3 Last Price March, 29 th 2016 R$ 13,97/share São Paulo, March 29, 2016. QUALICORP S.A (BM&FBOVESPA: QUAL3), one of the leading full-service healthcare benefits administrator

More information

Institutional Presentation

Institutional Presentation Institutional Presentation SULAMÉRICA BUSINESS MODEL Largest independent Brazilian insurer, with leadership position in different segments 120 years of successful history in Brazil One-stop shop for financial

More information

Qualicorp Consultoria e Corretora de

Qualicorp Consultoria e Corretora de Qualicorp Consultoria e Corretora de - Seguros S.A. 2Q18 Earnings Release Qualicorp Consultoria e Corretora de Seguros S.A. BOVESPA: QUAL3 Shares Outstanding () 283,176,826 shares Free Float () 282,276,689

More information

Investor Presentation

Investor Presentation Investor Presentation 3Q10 Growth for the next 115 years SULAMÉRICA TODAY A Unique Kind of Insurance Company Ranking as independent pure play Brazilian insurance company not owned by a bank #1 Ranking

More information

Earnings Release 4Q17. March 16 th, 2018

Earnings Release 4Q17. March 16 th, 2018 Earnings Release 4Q17 March 16 th, 2018 Legal Warning Forward-looking statements This release may contain forward-looking statements concerning the business outlook, estimates of operating and financial

More information

New growth cycle and value innovation. May, 2013

New growth cycle and value innovation. May, 2013 New growth cycle and value innovation May, 2013 Disclaimer The information contained herein has been prepared by Odontoprev S.A. ( OdontoPrev or the Company ) and this material does not constitute offering

More information

Investor Update 3Q10

Investor Update 3Q10 Investor Update 3Q10 SULAMÉRICA AT A GLANCE Largest independent Brazilian insurance group Solid reputation and widely-recognized brandname Multiline insurance business supported by high-quality products

More information

June IMC: Merger with Sapore

June IMC: Merger with Sapore June 2018 IMC: Merger with Sapore Disclaimer The material that follows is a presentation of general background information about International Meal Company Alimentação S.A. ( IMC or the Company ) as of

More information

Earnings Release 1Q18. May 11 th, 2018

Earnings Release 1Q18. May 11 th, 2018 Earnings Release 1Q18 May 11 th, 2018 Legal Warning Forward-looking statements This release may contain forward-looking statements concerning the business outlook, estimates of operating and financial

More information

2Q17 Results Presentation

2Q17 Results Presentation 2Q17 Results Presentation August 9, 2017 p. 1 2Q17 Highlights Growth of 97.4% in Net Income, reaching R$11.1 million in the quarter, Growth of 42.3% in the number of RAC daily rentals, to a record 2.7

More information

Earnings Release 2Q18. August 15 th, 2018

Earnings Release 2Q18. August 15 th, 2018 Earnings Release 2Q18 August 15 th, 2018 Legal Warning Forward-looking statements This release may contain forward-looking statements concerning the business outlook, estimates of operating and financial

More information

Corporate Presentation July New growth cycle and value innovation

Corporate Presentation July New growth cycle and value innovation Corporate Presentation July 2017 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Strategic competitive advantages 4 Financial and Operational

More information

Corporate presentation May 2017 FLRY3

Corporate presentation May 2017 FLRY3 Corporate presentation May 2017 FLRY3 Agenda Overview and Strategy Financial Performance Healthcare Sector in Brazil Expansion Plan Ownership Structure and Governance 2 Agenda Overview and Strategy Financial

More information

4Q17 and 2017 Earnings Release Resultados 4T12

4Q17 and 2017 Earnings Release Resultados 4T12 ex-inss: Revenues up 5.6%, with net adds of 34 thousand lives in the corporate segment. Dental care ratio down to 44.1%. Adjusted Ebitda up 30.9%, with margin expansion of 4.9 p.p. to 25.3%. Net cash of

More information

Earnings Release 4Q14

Earnings Release 4Q14 Earnings Release 4Q14 Earnings 4Q14 Fleury ON (Bovespa FLRY3) (Bloomberg FLRY3 BZ; Thomson FLRY3-BR) Debentures: BRFLRYDBS007, BRFLRYDBS015 e BRFLRYDBS023 On December 31 st 2014: Shares Outstanding 156,293,356

More information

Corporate presentation August 2017 FLRY3

Corporate presentation August 2017 FLRY3 Corporate presentation August 2017 FLRY3 Agenda Overview and Strategy Financial Performance Healthcare Sector in Brazil Expansion Plan Ownership Structure and Governance 2 Agenda Overview and Strategy

More information

Investor Presentation

Investor Presentation Investor Presentation 4Q10 Growth for the next 115 years SULAMÉRICA TODAY A Unique Kind of Insurance Company Ranking as independent pure play Brazilian insurance company not owned by a bank #1 Strong brand

More information

Earnings Release 4Q15 and 2015

Earnings Release 4Q15 and 2015 FOR IMMEDIATE RELEASE - São Paulo, March 3, 2016 Gafisa S.A. (Bovespa: GFSA3; NYSE: GFA), one of Brazil s leading homebuilders, today reported financial results for the fourth quarter and year ended December

More information

SulAmérica. Brazil 2008 UBS Pactual Ninth Annual CEO Conference February 19, 2008

SulAmérica. Brazil 2008 UBS Pactual Ninth Annual CEO Conference February 19, 2008 SulAmérica Brazil 2008 UBS Pactual Ninth Annual CEO Conference February 19, 2008 Disclaimer The material that follows is a presentation of general background information about Sul América S.A. ( SulAmérica

More information

Corporate presentation March 2018

Corporate presentation March 2018 Corporate presentation March 2018 Agenda Overview and Strategy Financial Performance Healthcare Sector in Brazil Expansion Plan Ownership Structure and Governance 2 Agenda Overview and Strategy Financial

More information

2Q17 and 6M17 Earnings Release Resultados 4T12

2Q17 and 6M17 Earnings Release Resultados 4T12 ex-inss: Revenues up 5%. Lower dental care ratio and decreasing bad debt expand adjusted EBITDA by 13%. EPS 17% higher. Cash dividends in the quarter reach R$111 million, 217% above 2Q16 Sao Paulo, July

More information

Brasil Brokers announces its 4Q08 results

Brasil Brokers announces its 4Q08 results Brasil Brokers announces its 4Q08 results Rio de Janeiro, March 16, 2009. Brasil Brokers Participações S.A. (Bovespa: BBRK3), a real estate brokerage and consulting firm with a strong presence in Brazil

More information

Institutional Presentation. November/December 2010

Institutional Presentation. November/December 2010 Institutional Presentation November/December 2010 Market Campaign 2 Gross Revenue (R$ Million) and EBITDA Margin (%) ¹ Success Track Record Foundation Strengthening/Expansion Operating Leverage 1,205 1,080

More information

Corporate Presentation February, New growth cycle and value innovation

Corporate Presentation February, New growth cycle and value innovation Corporate Presentation February, 2017 New growth cycle and value innovation Dental benefits: an incipient sector in Brazil 2 Brazilian dental opportunity 60% 11% % of the population covered by a private

More information

3Q12 Earnings Release

3Q12 Earnings Release 3Q12 Earnings Release Qualicorp S.A. BOVESPA:QUAL3 Last Price November, 12 th 2015 R$ 16.48/share São Paulo, November 12, 2015. QUALICORP S.A (BM&FBOVESPA: QUAL3), one of the leading full-service healthcare

More information

Localiza Rent a Car S.A.

Localiza Rent a Car S.A. Localiza Rent a Car S.A. Confins airport branch Belo Horizonte 24h reservation 0800 979 2000 www.localiza.com 1 Integrated business platform 28,080 cars 172 agencies 1.2 million clients 16,600 cars 405

More information

Institutional Presentation. September/October 2010

Institutional Presentation. September/October 2010 Institutional Presentation September/October 2010 Market Campaign 2 Success Track Record Foundation Strengthening / Expansion Operating Leverage 1,153 1,080 25.2% Gross Revenue (R$ million) and EBITDA

More information

Odontoprev S.A. Interim Financial statements as of June 30, 2016 Quarterly Information - ITR (A free translation of the original report in Portuguese)

Odontoprev S.A. Interim Financial statements as of June 30, 2016 Quarterly Information - ITR (A free translation of the original report in Portuguese) Interim Financial statements as of June 30, 2016 Quarterly Information - ITR (A free translation of the original report in Portuguese) Interim Financial Statements as of June 30, 2016 Quarterly Information

More information

Corporate presentation August 2018

Corporate presentation August 2018 Corporate presentation August 2018 Agenda Overview and Strategy Financial Performance Healthcare Sector in Brazil Expansion Plan Ownership Structure and Governance 2 Agenda Overview and Strategy Financial

More information

WYNDHAM DESTINATIONS Supplementary Financial Information

WYNDHAM DESTINATIONS Supplementary Financial Information WYNDHAM DESTINATIONS Supplementary Financial Information May 2, 2018 Disclaimers Certain statements in this presentation constitute forward-looking statements within the meaning of Section 27A of the Securities

More information

Institutional Presentation. February/March 2011

Institutional Presentation. February/March 2011 Institutional Presentation February/March 2011 Marketing Campaign SHARE THE NEW WORLD Technology, Software (SaaS), Social Network and Consulting 2 Gross Revenue (R$ Million) and EBITDA Margin (%) ¹ 3 Success

More information

IR CONTACTS 3Q16 - EARNINGS RELEASE

IR CONTACTS 3Q16 - EARNINGS RELEASE São Paulo, November 3, 2016 TOTVS S.A. (BM&FBOVESPA: TOTS3), the leading developer of business solutions in Brazil and Latin America, announces today its results of the third quarter of 2016 (3Q16). The

More information

Earnings Release - 2Q14

Earnings Release - 2Q14 Earnings Release - 2Q14 Barueri, July 31, 2014 Smiles S.A. (BM&FBOVESPA: SMLE3), one of the largest loyalty programs in Brazil with over 10 million members, announces today its results for 1Q14. The financial

More information

Results Presentation 4Q16 and FY2016 March 27th

Results Presentation 4Q16 and FY2016 March 27th Results Presentation 4Q16 and FY2016 March 27th 2017 1 Disclaimer The material that follows is a presentation of general background information about ENEVA S.A. and its subsidiaries (collectively, ENEVA

More information

Institutional Presentation. July / Aug 2010

Institutional Presentation. July / Aug 2010 Institutional Presentation July / Aug 2010 Market Campaign 2 Success Track Record Foundation Strengthening / Expansion Operating Leverage 1,153 1,080 25.2% Gross Revenue (R$ million) and EBITDA Margin

More information

Quarterly Results 1 st quarter 2018

Quarterly Results 1 st quarter 2018 Quarterly Results 1 st quarter 2018 Total revenues of R$4.8 billion (+12.0%) Net income of R$141.4 million (+10.0%) Combined ratio of 98.6%, an improvement of 230 BPS Total health & dental insured members

More information

1Q16 Results. Investor Relations Contact: Felipe Enck Gonçalves CFO and Investor Relations Director

1Q16 Results. Investor Relations Contact: Felipe Enck Gonçalves CFO and Investor Relations Director 1Q16 Results Investor Relations Contact: Felipe Enck Gonçalves CFO and Investor Relations Director +55 (31) 3615-8400 ri@logcp.com.br www.logcp.com.br/relacoes-com-investidores A LOG COMMERCIAL PROPERTIES

More information

Quarterly Results 3Q16 November 16th

Quarterly Results 3Q16 November 16th Quarterly Results 3Q16 November 16th 2016 1 Disclaimer The material that follows is a presentation of general background information about ENEVA S.A. and its subsidiaries (collectively, ENEVA or the Company

More information

T4F Entretenimento S.A.

T4F Entretenimento S.A. T4F Entretenimento S.A. 1Q17 Earnings Release T4F Entretenimento S.A. BM&FBOVESPA: SHOW3 Quotation Closing on 03/31/2017: R$6.41 1Q17 Average Volume: 109.0 thousand (0.33% of the free float) Price on 05/10/2017:

More information

Earnings Release - 1Q18

Earnings Release - 1Q18 Earnings Release - 1Q18 Fortaleza (CE), May 14 th 2018 Hapvida Participações e Investimentos S.A. (B3:HAPV3), the third largest health and dental plan operator in Brazil, and absolute leader in the country's

More information

Investor Presentation 3Q16

Investor Presentation 3Q16 Investor Presentation 3Q16 Who are we? Largest mall company in Latin America The most efficient company with the best margins The only shopping mall company in Brazil with nationwide presence Portfolio

More information

2016 and 4Q16 Results FLRY3. March 2017

2016 and 4Q16 Results FLRY3. March 2017 2016 and Results FLRY3 March 2017 Disclosure This presentation may contain forward-looking statements. Such statements are not statements of historical facts and reflect the beliefs and expectations of

More information

Credit Opinion: Fleury SA

Credit Opinion: Fleury SA Credit Opinion: Fleury SA Global Credit Research - 01 Mar 2016 Brazil Ratings Category Outlook Corporate Family Rating -Dom Curr Senior Unsecured -Dom Curr NSR Corporate Family Rating NSR Senior Unsecured

More information

Reinforcing our undisputed leadership in the wireless sector in Brazil through the acquisition of

Reinforcing our undisputed leadership in the wireless sector in Brazil through the acquisition of Reinforcing our undisputed leadership in the wireless sector in Brazil through the acquisition of January 16 th, 2003 Safe Harbour This presentation contains statements that constitute forward-looking

More information

2Q10 Conference Call Presentation (Only in Portuguese)

2Q10 Conference Call Presentation (Only in Portuguese) 2Q10 Conference Call Presentation (Only in Portuguese) Agenda Funding Page 3 Daycred Auto Loans Page 10 Foreign Currency Funding Page 4 Daycred DCC Retailers Page 11 Liquidity Page 5 Quality of Loan Portfolio

More information

Tempo Assist announces year-on-year Net Revenue and Net Income growth of 24.7% and 90.0%, respectively, in 1Q11

Tempo Assist announces year-on-year Net Revenue and Net Income growth of 24.7% and 90.0%, respectively, in 1Q11 Capital Stock as of March 31 st, 2011 Total Shares 156.285.611 (-) Treasury 6.832.458 Outstanding 149.453.153 Tempo Assist announces year-on-year Net Revenue and Net Income growth of 24.7% and 90.0%, respectively,

More information

FIRST QUARTER OF 2018 RESULTS

FIRST QUARTER OF 2018 RESULTS FIRST QUARTER OF 2018 RESULTS São Paulo, May 07, 2018. Linx S.A. (B3: LINX3; Bloomberg: LINX3:BZ e Reuters: LINX3.SA), announces its consolidated results for the first quarter of 2018 (). The Company s

More information

3Q10 Conference Call Presentation (Only in Portuguese)

3Q10 Conference Call Presentation (Only in Portuguese) 3Q10 Conference Call Presentation (Only in Portuguese) 2 Agenda Key Figures Page 3 Funding Page 4 Daycred DCC Retailers Asset Management Page 14 Page 15 Foreign Currency Funding Page 6 Quality of Loan

More information

Banco Santander (Brasil) S.A.

Banco Santander (Brasil) S.A. Banco Santander (Brasil) S.A. 9M09 IFRS Results Pro forma October 28th, 2009 Table of Contents 2 Macroeconomic Scenario and Financial System 9M09 - Strategy -Results - Business Macroeconomic Scenario 3

More information

EAST BALT BAKERIES July 2017 ACQUISITION

EAST BALT BAKERIES July 2017 ACQUISITION EAST BALT BAKERIES July 2017 ACQUISITION E AST BA LT AT A G L A N C E Leading foodservice-focused company that supplies baked goods to Quick Service Restaurants ( QSR ) across the world Operates 21 bakeries

More information

Institutional Presentation. November 2018

Institutional Presentation. November 2018 Institutional Presentation November 2018 3 Over 40 years of history 2006 Acquisition of interest by Spinnaker 1974 abc investmob is founded 1999 ISO 9000 Cetification ERP system is implemented Even Rio

More information

Highlights of the period

Highlights of the period GROWTH IN REVENUES AND ADJUSTED EBITDA São Paulo, November 06, 2017. A Linx S.A. (B3: LINX3; Bloomberg: LINX3:BZ and Reuters: LINX3.SA), the leader in management software for retailers, announced its consolidated

More information

TIM Participações S.A.

TIM Participações S.A. TIM PARTICIPAÇÕES S.A. Announces its Consolidated Results for the First Quarter of 2006 May 04, 2006 BOVESPA (lot of 1,000 shares) TCSL3: R$10.19 TCSL4: R$ 8.40 NYSE (1 ADR = 10,000 shares) TSU: US$ 40.60

More information

Conference Call 3Q17 and 9M17 11/01/2017 at 09:00 am (NY time)

Conference Call 3Q17 and 9M17 11/01/2017 at 09:00 am (NY time) Conference Call 11/01/2017 at 09:00 am (NY time) Disclaimer The forward-looking statements in the conference call are based on the beliefs and assumptions of Porto Seguro s management, and on information

More information

Reduction of 445 p.p. in net debt to equity (% Rossi) 4Q17 vs. 3Q17

Reduction of 445 p.p. in net debt to equity (% Rossi) 4Q17 vs. 3Q17 Conference Call São Paulo, March 26, 2018. Rossi Residencial S.A. (BM&FBovespa: RSID3; Bloomberg: RSID3 BZ Equity), announces its results for the fourth quarter and the year of 2017. RSID3: R$ 6.40 per

More information

3Q16 results FLRY3. October 2016

3Q16 results FLRY3. October 2016 results FLRY3 October 2016 Disclosure This presentation may contain forward-looking statements. Such statements are not statements of historical facts and reflect the beliefs and expectations of the Company

More information

Results 3Q17 FLRY3. October 2017

Results 3Q17 FLRY3. October 2017 Results 3Q17 FLRY3 October 2017 Disclosure This presentation may contain forward-looking statements. Such statements are not statements of historical facts and reflect the beliefs and expectations of the

More information

Institutional Presentation. 4Q07 Results

Institutional Presentation. 4Q07 Results Institutional Presentation 4Q07 Results AGENDA About Banco Daycoval Page 3 Initial Public Offering (IPO) Page 8 Our Businesses Model Page 12 Results Page 19 Corporate Governance, IR, Awards and Recent

More information

Data Consolidation of the Private Equity and Venture Capital Industry in Brazil. kpmg.com/br

Data Consolidation of the Private Equity and Venture Capital Industry in Brazil. kpmg.com/br Data Consolidation of the Private Equity and Venture Capital Industry in Brazil kpmg.com/br www.abvcap.com.br 2 Data Consolidation of the Private Equity and Venture Capital Industry in Brazil Data Consolidation

More information

SS&C Technologies (NASDAQ:SSNC) Investor Presentation February 2015

SS&C Technologies (NASDAQ:SSNC) Investor Presentation February 2015 SS&C Technologies (NASDAQ:SSNC) Investor Presentation February 2015 Safe Harbor Statement Safe Harbor Statement This presentation includes forward-looking statements that are based on the current expectations

More information

Raia Drogasil S.A. Quarterly Information (ITR) at March 31, 2018 and report on review of quarterly information

Raia Drogasil S.A. Quarterly Information (ITR) at March 31, 2018 and report on review of quarterly information Raia Drogasil S.A. Quarterly Information (ITR) at March 31, 2018 and report on review of quarterly information Contents Company information Capital composition 1 Dividends 2 Parent company financial information

More information

Corporate Presentation 2Q18. New growth cycle and value innovation

Corporate Presentation 2Q18. New growth cycle and value innovation Corporate Presentation 2Q18 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev: strategic competitive advantages 3 Financial and Operational

More information

Investor Presentation First Quarter 2016

Investor Presentation First Quarter 2016 Investor Presentation First Quarter 2016 Control Group: 77% Float: 23% Market Cap: US$14.2 bn (1) LTM 1Q 16 Revenues (2) Countries Plants Routes Sales Centers POS Associates Brands Products US$13.6 Bn

More information

2Q10 Results. August, 2010 FLRY3

2Q10 Results. August, 2010 FLRY3 2Q10 Results FLRY3 The most valuable brand in the Brazilian healthcare industry The 6th most valuable brand among the service companies The 25th most valuable Brazilian brand Millward Brand / BrandAnalytics

More information

SS&C Technologies (NASDAQ:SSNC)

SS&C Technologies (NASDAQ:SSNC) SS&C Technologies (NASDAQ:SSNC) Leading Software Provider to the Institutional, Alternative and Wealth Management Markets SS&C to Acquire DST Systems January 11, 2018 Safe Harbor Statement Safe Harbor

More information

1Q14 Earnings Release

1Q14 Earnings Release 1Q14 Earnings Release Barueri, May 6, 2014 Smiles S.A. (BM&FBOVESPA: SMLE3), one of the largest coalition programs in Brazil, with over 9.9 million members, announces today its results for 1Q14. The financial

More information

INVESTOR PRESENTATION Results 2Q2018. August 16, 2018

INVESTOR PRESENTATION Results 2Q2018. August 16, 2018 INVESTOR PRESENTATION Results 2Q2018 August 16, 2018 RESULTS SECOND QUARTER 2018 DISCLAIMER This presentation provides general information about Sociedad Matriz SAAM S.A. ( SMSAAM ) and related companies.

More information

Corporate Presentation July New growth cycle and value innovation

Corporate Presentation July New growth cycle and value innovation Corporate Presentation July 2018 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev: strategic competitive advantages 3 Financial and Operational

More information

DIRECIONAL ANNOUNCES RESULTS OF 3Q18 WITH CASH GENERATION OF BRL 287 MILLION AND 54% INCREASE IN NET REVENUE COMPARED TO 3Q17.

DIRECIONAL ANNOUNCES RESULTS OF 3Q18 WITH CASH GENERATION OF BRL 287 MILLION AND 54% INCREASE IN NET REVENUE COMPARED TO 3Q17. RELEASE OF RESULTS Belo Horizonte, November 08, 2018 - The Direcional Engenharia S.A., one of the largest real estate development and construction companies in Brazil, with focus on the development of

More information

Investor Presentation 4Q16

Investor Presentation 4Q16 Investor Presentation 4Q16 1 Who we are? Largest mall company in Latin America The only shopping mall company in Brazil with nationwide presence Portfolio with 44 regional malls, almost 8% of the total

More information

GLOBO CABO REDUCES DEBT AND INCREASES MARGINS WHILE FACING SMALL DECLINE IN SUBSCRIBER BASE.

GLOBO CABO REDUCES DEBT AND INCREASES MARGINS WHILE FACING SMALL DECLINE IN SUBSCRIBER BASE. Globo Cabo S.A. Av. Rio Branco n o 1-6º Andar Centro - Rio de Janeiro - RJ CEP 20090-003 Tel: (55 21) 276-6055 Fax: (55 21) 276-6955 NEWS RELEASE Investor Relations Globo Cabo S.A. 55-21-276-6055 Curtis

More information

4Q16 Earnings Release

4Q16 Earnings Release 4Q16 Earnings Release Barueri, February 15, 2017 Smiles S.A. (BM&FBOVESPA: SMLE3) one of the largest loyalty programs in Brazil with over 12 million members, announces today its 4Q16 results. The financial

More information

Annual Meeting

Annual Meeting 1 Agenda 1 Accredited dentist network 2 Sustainability & marketing 3 Innovation and digital transformation 4 Results and value driven Company 5 Odonto System acquisition 6 Final considerations 2 José Roberto

More information

Dear fellow Shareholders:

Dear fellow Shareholders: Dear fellow Shareholders: Morgan Stanley made significant progress driving forward our business and strategy during 2010. We leveraged our unique position in the marketplace and our unparalleled global

More information

GAFISA RELEASES 3Q16 RESULTS

GAFISA RELEASES 3Q16 RESULTS Conference Call November 9, 2016 8:00 am US EST In English (simultaneous translation from Portuguese) + 1-516-3001066 US EST Code: Gafisa 11h00 am Brasilia Time In Portuguese Telephone: +55-11-3728-5971

More information

April 26, Q11 Earnings Release. April 27, 2011

April 26, Q11 Earnings Release. April 27, 2011 April 26, 2011 1Q11 Earnings Release Share Price (03/31/2011) ROMI3 R$ 11.25/share Market Capitalization (03/31/2011) R$ 841 million US$ 516 million Number of shares (03/31/2011) Common: 74,757,547 Total:

More information

3Q14 Earnings Conference Call

3Q14 Earnings Conference Call 3Q14 Earnings Conference Call 2 Group Overview CONTAX IS THE LEADING CRM BPO COMPANY IN SOUTH AMERICA Contax Group at a glance Contax Group footprint and portfolio of services Contax Group Highlights 4

More information

4Q15 and 2015 Results

4Q15 and 2015 Results 4Q15 and 2015 Results Investor Relations Contacts: Felipe Enck Gonçalves CFO and Investor Relations +55 (31) 3615-8400 ri@logcp.com.br www.logcp.com.br/relacoes-com-investidores 1 A LOG COMMERCIAL PROPERTIES

More information

New growth cycle and value innovation. Webcast 3Q13

New growth cycle and value innovation. Webcast 3Q13 New growth cycle and value innovation Webcast 3Q13 Disclaimer The information contained herein has been prepared by Odontoprev S.A. ( OdontoPrev or the Company ) and this material does not constitute offering

More information

NOVEMBER Investor Presentation

NOVEMBER Investor Presentation NOVEMBER 2018 Investor Presentation Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (Securities

More information

3 rd QUARTER REPORT ON ECONOMIC AND FINANCIAL ANALYSIS

3 rd QUARTER REPORT ON ECONOMIC AND FINANCIAL ANALYSIS 3 rd QUARTER 2018 REPORT ON ECONOMIC AND FINANCIAL ANALYSIS rrrr Table of contents 1 - Press Release 3 Main Information 4 Recurring Net Income vs. Book Net Income 5 Summarized Analysis of Recurring Income

More information

PSV totals R$627 million Contracted sales grow by 110% (R$351 million)

PSV totals R$627 million Contracted sales grow by 110% (R$351 million) PSV totals R$627 million Contracted sales grow by 110% (R$351 million) São Paulo, November 13, 2007 Rossi Residencial S.A. (Bovespa: RSID3), one of the main residential real estate developers in Brazil,

More information

Earnings Conference Call 2Q18. August 15, 2018

Earnings Conference Call 2Q18. August 15, 2018 Earnings Conference Call August 15, 2018 Disclaimer This material is a presentation of general information about Marfrig Global Foods S.A. and its consolidated subsidiaries (jointly the Corporation ) on

More information

Acquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender. May 18, 2017

Acquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender. May 18, 2017 Acquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender May 18, 2017 1 Disclaimer & Prospectus Information This presentation has been prepared by Laurentian Bank

More information

2Q15 Earnings Release

2Q15 Earnings Release 2Q15 Earnings Release Barueri, August 4, 2015 - Smiles S.A. (BM&FBOVESPA: SMLE3), one of the largest loyalty programs in Brazil with over 10 million members, announces today its results for 2Q15. The financial

More information

1Q18 Earnings Release Resultados 4T12

1Q18 Earnings Release Resultados 4T12 : Revenues up 5.4%, with net adds of 29 thousand lives in the quarter, from all three segments. Lower dental care ratio expands adjusted Ebitda 17.7%, with margin expansion of 300 bps to 28.7%. Net income

More information

3Q17 HIGHLIGHTS. Gross margin 43.8% 47.0% 3.2p.p. 46.1% 47.9% 1.7p.p. Net margin -7.8% -9.2% -1.4p.p. -9.7% -7.4% 2.3p.p.

3Q17 HIGHLIGHTS. Gross margin 43.8% 47.0% 3.2p.p. 46.1% 47.9% 1.7p.p. Net margin -7.8% -9.2% -1.4p.p. -9.7% -7.4% 2.3p.p. 3Q17 RESULTS GRUPO TECHNOS ANNOUNCES 3Q17 EARNINGS RESULTS Rio de Janeiro, October 26, 2017 Grupo Technos (BM&FBovespa: TECN3) announces its 3Q results. The following financial and operational information

More information